Systems and methods for fabricating microfluidic devices

Patent metadata

Field	Value
Publication number	US-11278885-B2
Application number	US-201816116637-A
Country	US
Kind code	B2
Filing date	Aug 29, 2018
Priority date	Aug 30, 2017
Publication date	Mar 22, 2022
Grant date	Mar 22, 2022

Abstract

This disclosure describes techniques for fabricating a high-resolution, non-cytotoxic and transparent microfluidic device. A material can be selected based on having an optical property with a predetermined degree of transparency to provide viewability of a biological sample through the microfluidic device and a level of cytotoxicity within a predetermined threshold to provide viability of the biological sample within the microfluidic device. An additive manufacturing technique can be selected from a plurality of additive manufacturing techniques for fabricating the microfluidic device based on the selected material to provide a resolution of dimensions of one or more channels of the microfluidic device higher than a predetermined resolution threshold.

First claim

We claim:

1. A microfluidic device, comprising:
a single piece construction comprising one or more channels, wherein a resolution of dimensions of the one or more channels is higher than a predetermined resolution threshold of less than 100, 150, 200 or 250 microns;
wherein the microfluidic device is constructed using an additive manufacturing technique selected to provide the resolution of dimensions of the one or more channels are higher than the predetermined resolution threshold of 100, 150, 200 or 250 microns or less;
wherein the microfluidic device is constructed by sequentially applying the additive manufacturing technique to a microfluidic device material to create a plurality of layers of the microfluidic device, based on a model for the microfluidic device and a plurality of parameters;
wherein the microfluidic device comprises a photopolymerizable polymer selected from a group consisting of a polyethyl methacrylate polymer (PEMA) or a polyethyl methacrylate-polymethyl methacrylate copolymer (PEMA-PMMA); and
wherein the microfluidic device material exhibits (1) non-cytotoxicity over an extended period of time, (2) optical transparency to visible light, (3) little to no auto-fluorescence to enable data capture of the microfluidic device operation via fluorescent images, and (4) high-resolution fabrication to be able to reproduce small features of less than 100 microns.

2. The microfluidic device of claim 1 , wherein the additive manufacturing technique is 3D printing.

3. The microfluidic device of claim 1 , wherein the additive manufacturing technique comprises one of stereolithography (SLA) or digital light projection stereolithography (SLA-DLP).

4. The microfluidic device of claim 1 , wherein the plurality of parameters comprises a predetermined parameter for layer thickness.

5. The microfluidic device of claim 4 , wherein the predetermined parameter for layer thickness is in the range of about 0.001 millimeters to about 0.5 millimeters.

6. The microfluidic device of claim 4 , wherein the plurality of parameters comprises a predetermined parameter for curing thickness offset.

7. The microfluidic device of claim 6 , wherein the predetermined parameter for curing thickness offset is in the range of about 0.01 millimeters to about 0.3 millimeters.

8. The microfluidic device of claim 1 , wherein the one or more channels of the microfluidic device have a height in the range of about 0.01 millimeters to about 2.5 millimeters and a width in the range of about 0.01 millimeters to about 2.5 millimeters.

9. The microfluidic device of claim 1 , wherein the microfluidic device material provides survival of at least 90% of cells included in a biological sample over for at least one week.

10. The microfluidic device of claim 1 wherein the microfluidic device material includes at least 50%, or 60% or 70% by weight of polyethyl methacrylate polymer or copolymer.

11. The microfluidic device of claim 10 wherein at least 90% or at least 95% by mass of the microfluidic device material includes polyethyl methacrylate polymer or polyethyl methacrylate copolymer, and a second monomer in which the polyethyl methacrylate polymer is at least partially soluble and comprises an alkyl acrylate or an alkyl methacrylate monomer, wherein the alkyl acrylate or the alkyl methacrylate monomer is a monomer of methacrylate group methyl methacrylate, ethyl methacrylate, ethyl acrylate, ethoxyethyl acrylate, tetrahydrofurfuryl methacrylate, tetrahydrofurfuryl acrylate, isobornyl acrylate or isobornyl methacrylate and ethoxyethyl methacrylate.

12. The microfluidic device of claim 11 , wherein the microfluidic device material includes a flexibilizer or a catalyst.

13. A microfluidic device, comprising:
a single piece construction comprising one or more channels, wherein a resolution of dimensions of the one or more channels is higher than a predetermined resolution threshold of less than 100, 150, 200 or 250 microns;
wherein the microfluidic device is constructed using an additive manufacturing technique, the additive manufacturing technique selected to provide the resolution of dimensions of the one or more channels are higher than the predetermined resolution threshold of 100, 150, 200 or 250 microns or less;
wherein the microfluidic device is constructed based on a model for the microfluidic device and a plurality of parameters, the plurality of parameters comprising a predetermined parameter for layer thickness and a predetermined parameter for curing thickness offset in the range of about 0.01 millimeters to about 0.3 millimeters; and
wherein the microfluidic device exhibits (1) non-cytotoxicity over an extended period of time, (2) optical transparency to visible light, (3) little to no auto-fluorescence to enable data capture of the microfluidic device operation via fluorescent images, and/or (4) high-resolution fabrication to be able to reproduce small features of less than 100 microns.

14. The microfluidic device of claim 13 , wherein the additive manufacturing technique is 3D printing.

15. The microfluidic device of claim 13 , wherein the additive manufacturing technique comprises one of stereolithography (SLA) or digital light projection stereolithography (SLA-DLP).

16. The microfluidic device of claim 13 , wherein the predetermined parameter for layer thickness is in the range of about 0.001 millimeters to about 0.5 millimeters.

17. The microfluidic device of claim 13 , wherein the one or more channels of the microfluidic device have a height in the range of about 0.01 millimeters to about 2.5 millimeters and a width in the range of about 0.01 millimeters to about 2.5 millimeters.

18. The microfluidic device of claim 13 , wherein the microfluidic device provides survival of at least 90% of cells included in a biological sample over for at least one week.

19. The microfluidic device of claim 13 , comprising a polymer selected from a group consisting of polyetheretherketone (“PEEK”), polymethylacrylamide or polyacrylamide, polyvinylalcohol, polycaprolactone and polylactide.

20. The microfluidic device of claim 13 comprising a photopolymerizable polymer selected from a group consisting of a polyethyl methacrylate polymer (PEMA) or a polyethyl methacrylate-polymethyl methacrylate copolymer (PEMA-PMMA).

21. The microfluidic device of claim 20 wherein the microfluidic device includes at least 50%, or 60% or 70% by weight of polyethyl methacrylate polymer or copolymer.

22. The microfluidic device of claim 21 wherein at least 90% or at least 95% by mass of the microfluidic device includes polyethyl methacrylate polymer or polyethyl methacrylate copolymer, and a second monomer in which the polyethyl methacrylate polymer is at least partially soluble and comprises an alkyl acrylate or an alkyl methacrylate monomer, wherein the alkyl acrylate or the alkyl methacrylate monomer is a monomer of methacrylate group methyl methacrylate, ethyl methacrylate, ethyl acrylate, ethoxyethyl acrylate, tetrahydrofurfuryl methacrylate, tetrahydrofurfuryl acrylate, isobornyl acrylate or isobornyl methacrylate and ethoxyethyl methacrylate.

23. The microfluidic device of claim 22 wherein the microfluidic device includes a flexibilizer or a catalyst.

24. A microfluidic device, comprising:
a single piece construction comprising one or more channels, wherein a resolution of dimensions of the one or more channels is higher than a predetermined resolution threshold of less than 100, 150, 2

Assignees

• Charles Stark Draper Laboratory Inc
• Massachusetts Inst Technology

Inventors

• Beckwith Ashley Lynne
• Borenstein Jeffrey
• Moore Nathan
• Doty Daniel
• Velásquez-Gracía Luis Fernando

Classifications

• B81C1/00071

  Channels · CPC title

• B81B2201/058

  Microfluidics not provided for in B81B2201/051 - B81B2201/054 · CPC title

• B01L3/502707 Primary

  characterised by the manufacture of the container or its components · CPC title

• B01L2300/123

  Flexible; Elastomeric · CPC title

• B01L2200/12

  Specific details about manufacturing devices · CPC title